# TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era

> **NCT05752019** · — · COMPLETED · sponsor: **Erasmus Medical Center** · enrollment: 103 (actual)

## Conditions studied

- Cystic Fibrosis
- Lung Inflammation
- Lung Infection
- Lung Disease; Cystic
- Lung Diseases
- Lung Disease; Cystic, Congenital
- Inflammation Lungs
- Congenital Disorders
- Exacerbation, Symptom
- Infections, Bacterial

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05752019
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-21
- **Primary completion:** 2023-11-09
- **Final completion:** 2024-12-31
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2025-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05752019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05752019, "TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05752019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*